Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 64, Issue 4, Pages 1008-1015Publisher
SPRINGER
DOI: 10.1007/s10620-019-05539-0
Keywords
Stereotactic; SBRT; Hepatocellular carcinoma; HCC; Hypofractionated; Radiation
Categories
Ask authors/readers for more resources
Hepatocellular carcinoma is a rising cause of morbidity and mortality in the USA and around the world. Surgical resection and liver transplantation are the preferred management strategies; however, less than 30% of patients are eligible for surgery. Stereotactic body radiation therapy is a promising local treatment option for non-surgical candidates. Local control rates between 95 and 100% have been reported at 1-2years post-treatment, and classical radiation-induced liver disease described with conventional radiation is an unlikely complication from stereotactic radiotherapy. Enrollment in randomized trials will be essential in establishing the role of stereotactic radiation in treatment paradigms for hepatocellular carcinoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available